# Corvex Inc. (MOVE) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Technology. Price $14.74, market value $465 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Corvex Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 104.9×**. Each dollar of revenue is priced at 104.9×, a level that requires very high margins or very fast growth to justify.

## Profitability
- **Operating margin: -610.3%**. Operating margin is negative: the business loses money before interest and tax.
- **Return on equity: 526.3%**. A 526.3% return on equity is extremely high; check whether buybacks or debt have shrunk the equity base, which flatters the ratio.
- **Return on assets: -493.8%**. Each dollar of assets produces -493.8% of profit.

## Growth
- **Revenue growth (1 yr): -57.3%**. Revenue fell 57.3% over the last year.
- **EPS growth (1 yr): 44.7%**. Earnings per share rose 44.7%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Current ratio: 0.57** (quick 0.57). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 20.01**. A Z-score of 20.01 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Corvex Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 85.3%** (YTD 140.9%, 3-mo -21.1%). The shares are up 85.3% over twelve months including dividends.
- **From 52-week high: -44.8%** (328.6% above the low). Trading 45% below its 52-week high, deep in a drawdown.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 63**. An RSI of 63 is neutral.
- **Beta (1 yr): 2.98** (volatility 246%). Beta of 2.98 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=MOVE · Page: https://foliofundamentals.com/stocks/move

Not investment advice.